Stay updated on CTX001 in Severe Sickle Cell: Clinical Trial

Sign up to get notified when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX001 in Severe Sickle Cell: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Hb SS disease has been added as a related disease term, and the Genetic and Rare Diseases Information Center has been added to the Resources section.
    Difference
    0.1%
    Check dated 2026-04-02T00:20:34.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed in the page footer as part of a site update.
    Difference
    0.0%
    Check dated 2026-03-18T17:42:14.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible changes to study details or content.
    Difference
    0.0%
    Check dated 2026-03-11T17:56:16.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government funding lapse notice and the previous Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T09:18:05.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding was added, including a statement that the NIH Clinical Center is open and guidance to check cc.nih.gov and opm.gov for updates. The page revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:14:45.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The update adds a glossary toggle display and updates QC-related metadata labels (Last Update Submitted that Met QC Criteria) with revision tag v3.4.0, replacing v3.3.4. Core study content, outcomes, and eligibility criteria remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T02:38:25.000Z thumbnail image

Stay in the know with updates to CTX001 in Severe Sickle Cell: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.